November 2024 FDA Recall Drug by Trinity Gold Nutrition
D-0042-2025 - Marketed without an Approved NDA/ANDA

This Class II drug recall was voluntarily initiated by Trinity Gold Nutrition on November 6, 2024 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0042-2025

Reason for Recall
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac and phenylbutazone.
Initiated
11-06-2024
Reported
11-20-2024
Quantity
150

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Trinity Gold Nutrition
Nationwide within the United States; additionally Canada, England, and Australia.
Trinity Gold Nutrition, 60 Capsule, 30 day Supply, Distributed by Trinity Gold Nutrition 201 Tom Hall St. Ste. 2107, Fortmill, SC 29716, USA, Ph: 704-629-8203, www.trinitygold.com, Made in India, UPC 802992001009

Batch or Lot Expiration Information

Lot# : IN-030, Exp. Date: NOV 2027